jsmc-10149

MITOCHONDRIAL ENZYMES CORRELATION WITH BREAST CANCER CLINICOPATHOLOGICAL PARAMETERS/ A STUDY IN SULAIMANI CITY-IRAQ  

Hadeel Adnan Yasseen a, Rawand Tajuldeen Sahib b and Shahow Abdulrehman Ezzaddin C

a Department of Pathology, College of Medicine, University of Sulaimani. 

b Ministry of Health.

c Department of Community Medicine, College of Medicine, University of Sulaimani.

Submitted: 30/9/2017; Accepted: 7/2/2017; Published 15/4/2018

DOI Link: https://doi.org/10.17656/jsmc.10149 

ABSTRACT

Background 

Thousands of researches are done for breast cancer, but still cancer epithelial cells relationship with the surrounding stromal cells is a great topic for researchers which is termed the tumor microenvironment.

Objectives 

This study is designed to confirm that presence of the two main mitochondrial enzymes that act in ketone bodies production and utilization and their correlation with the clinicopathological parameters and tumor aggressiveness.

Materials and Methods

This cross sectional study was carried out in Iraq in which 40 selected cases of breast invasive ductal carcinoma not otherwise specified were stained immunohistochemically for two mitochondrial enzymes; HMGCS2 and ACAT1involved in ketone bodies production and utilization respectively and correlate their positivity with clinicopathological parameters of the breast cancer as patient’s age, estrogen and progesterone receptors, HER2, molecular types, tumor grade and lymph node metastasis.

Results

Out of 40 cases, 50% are in the age range of 41-50 years.  Grade I seen in 7%, grade II in 23% and grade III in 70% of cases. Regarding lymph node status, 10% are N2 while 28% are N3. ACAT1 shows stromal significant positivity with N3 only (P. = 0.01). HMGCS2 shows a highly significant epithelial positivity with N2 (P. = 0.004) and a significant stromal positivity with low grade tumors (P. = 0.04). 

Conclusion

No significant correlation between ketone bodies production or utilization with the studied clinicopathological parameters apart from tumor grade and lymph node status, indicating that aggressive and metastatic tumors are more capable of self dependence for feeding themselves with ketone bodies.

KEYWORDS

Ketone bodies, Breast cancer, Mitochondrial enzymes, ACAT1, HMGCS2

References 

1. Duffy, Michael J. The biochemistry of metastasis. Advances in Clinical Chemistry. 1996. 32: 135–160. 

2. Alyssa M. Dixon and Michael Weichhaus. Breast cancer metabolism: Are ketone bodies energetic substrates. Annual Meeting 2016; April 16-20, 2016; New Orleans, LA

3. Ferrier, Denise R., and Richard A. Harvey. Lippincott’s Illustrated Reviews: Biochemistry. Philadelphia: Wolters Kluwer Health, 2014:194

4. Nelson, David L., Michael M. Cox, and Albert L. Lehninger. Lehninger Principles of Biochemistry. 6th ed. New York: W.H. Freeman, 2013: 1105

5. Alwan NA. Breast cancer: demographic characteristics and clinico-pathological presentation of patients in Iraq. East Mediterr Health J. 2010 Nov;16(11):1159-64.

6. Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol. 2008 Jul 1;26(19):3153-8. 

7. Brouckaert O, Laenen A, Vanderhaegen J, Wildiers H, Leunen K, Amant F et al. Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers. Ann Oncol. 2012 Oct;23(10):2578-84

8. Minicozzi P, Bella F, Toss A, Giacomin A, Fusco M, Zarcone M, et al. Relative and disease-free survival for breast cancer in relation to subtype: a population-based study. J Cancer Res Clin Oncol. 2013 Sep;139(9):1569-77. 

9. Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marmé F,et al. Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study. BMC Cancer. 2016 Sep 15;16(1):734. 

10.  Jiayu Wang, Die Sang, Binghe Xu, Peng Yuan, Fei Ma, Yang Luo. Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population. Medicine (Baltimore). 2016 May; 95(18): e3518.

11. Punit Saraon, Daniela Cretu, Natasha Musrap, George S. Karagiannis, Ihor Batruch, Andrei P. Drabovich et al. Quantitative Proteomics Reveals That Enzymes of the Ketogenic Pathway Are Associated with Prostate Cancer Progression. Mol Cell Proteomics. 2013 Jun; 12(6): 1589–1601.

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.